ClinicalTrials.gg
Biological

4CMenB vaccine clinical trials

studies test it
50
open now
5
in phase 3
20
first study started
2006

Counted the way a researcher would: 4CMenB vaccine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses 4CMenB vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the 4CMenB vaccine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Oct 2014 · Trumenba · BLA 125549 (FDA, Purple Book)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bexsero
22
rMenB+OMV NZ
9
Meningococcal Group B Vaccine
5
4CMenB
5
4CMenB vaccine
3

In one entry with another drug

Given together, or one or the other

rLP2086
6
Trumenba
3

Studies by the year they started

50 studies that test it; most in 2014 (5)

Studies that test 4CMenB vaccine, by start year
YearStudies
20062
20071
20082
20092
20102
20112
20121
20134
20145
20152
20174
20181
20193
20204
20214
20222
20233
20242
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
17
Phase 3
20
Phase 4
13
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 20

Novartis Vaccines (10) · Pfizer (9) · GlaxoSmithKline (7) · University of Oxford (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · University of North Carolina, Chapel Hill (2) · Sanofi Pasteur, a Sanofi Company (2) · Canadian Immunization Research Network (2)

Often tested with

Tested in the same studies.

MenB-FHbp vaccine (9) · Meningococcal pentavalent vaccine (5) · Meningococcal Vaccines (4) · MenACWY (2) · Influenza Vaccines (1) · Hepatitis A Vaccines (1) · Antipyretics (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test 4CMenB vaccine.

Studies

Open first, then newest update. How each study uses 4CMenB vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 50

See all 50 studies that test 4CMenB vaccine →

Given beside what is tested · 5 — 4CMenB vaccine is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with 4CMenB vaccine

What changed recently

From the registry's own updates since Oct 18, 2026.